Table 2 RFFIT of RAB1, RAB2 and R172 against North America terrestrial isolates.

From: A cocktail of human monoclonal antibodies broadly neutralizes North American rabies virus variants as a promising candidate for rabies post-exposure prophylaxis

Viral isolate

Source (location)

Epitopeb

RAB1

RAB2

R172

HRIG

TX Coyote 323R

Coyote (Texas)

ENR

++

+

++

54

AK Fox

Fox (Alaska)

ENR

++

++

++

78

CA SK

Skunk (California)

ENR

++

++

++

48

PR Mong

Mongoose (Puerto Rico)

ENR

++

++

++

86

Sonora Dog

Dog (Mexico)

ENR

++

++

++

50

TXSK 4380

Skunk (Texas)

ENR

++

++

++

175

TXSK 5171

Skunk (Texas)

ENR

++wt

++

++

26

a

ERA

Lab Strain

ENR

++

++

++

67

NCSK

Skunk (North-central US)

ENK

++

++

++

49

TXFX

Fox (Texas)

ENK

++

++

++

40

RAC

Raccoon (Southeast US)

ESR

++

++

++

37

CVS-11

Lab Strain

EDR

+

++

++

25

  1. ++EC50 < 1 µg/mL.
  2. +EC50 ≥ 1 µg /mL.
  3. − Not neutralized by HuMAb at the highest concentration tested.
  4. HRIG potency IU/mL against given isolate.
  5. aLab-acquired mutation I338T identified in TKSK 5171 following additional cell culture passage. A primary wild type (wt) isolate tested.
  6. bEpitope variants with the noted residues at positions 33, 336, and 346.